
Cancer Genetics (CGIX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Cancer Genetics (CGIX) Stock
Start investing in Cancer Genetics (CGIX)
About Cancer Genetics (CGIX)
Market cap | $1.23M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 18.28K |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -0.09x |
Today's range | — |
Debt / equity | — |
52 week range | $0.14 - $1.58 |
5 year debt / equity | -15.01x |
Beta (LTM) | 0.99x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Mar 31, 2021 |
Dividend payable date | — |
Cancer Genetics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy CGIX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in CGIX stock
Navigate to the Explore page. Then, type CGIX into the search bar. When you see CGIX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased CGIX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Cancer Genetics Stock Earnings
The value each CGIX share was expected to gain vs. the value that each CGIX share actually gained.
Cancer Genetics (CGIX) reported earnings per share (EPS) of $0, — estimates of $0 by —. In the same quarter last year, Cancer Genetics's earnings per share (EPS) was $0. Cancer Genetics is expected to release next earnings on 03/31/2021, with an earnings per share (EPS) estimate of $0.